For instance, rs4442975, a strong candidate for causality, flanks a transcriptional enhancer that physically interacts with the promoter of IGFBP5. Researchers have demonstrated that rs4442975 is associated with FOXA1 binding and the low expression of IGFBP5 increased breast cancer susceptibility. Here, IGFBP5 is linked to breast cancer.